This was illustrated in a recent study, where C-X-C chemokine receptor type 4 (Cxcr4)-deficient stroke mice showed decreasing monocyte infiltration and increasing expression of microglia pro-inflammatory factors that translated into worse functional outcomes [78]. This evidence concerns the gene CXCR4 and stroke disorder.